AUDREY BELL: Open Payments
NPI 1578349742 · TEMECULA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 15 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $469 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $142 |
| AstraZeneca Pharmaceuticals LP | 5 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Currax Pharmaceuticals LLC | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
Products named: Ozempic, AIRSUPRA, Kerendia, CONTRAVE, UBRELVY, BREZTRI.
Industry payments across CA — which companies pay providers there.
